Arkolith/Insider Trading/MEIP/Form 4

Gold Daniel P PHD

Chief Executive Officer, DirectorMEI Pharma, Inc. (MEIP) · full profile →Form 4 · filed May 27, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2021Option exercise(M)5K$2.52$13K459K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 25, 2021Option exercise(M)5K—$0675K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-036188) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML